Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quoin Pharmaceuticals

8.47
-0.0200-0.24%
Volume:11.78K
Turnover:98.36K
Market Cap:4.98M
PE:-0.22
High:8.52
Open:8.31
Low:8.20
Close:8.49
Loading ...

Quoin Pharmaceuticals Ltd. Announces 2024 Annual Cash Bonuses for CEO and COO

Reuters
·
05 Jun

Quoin Pharmaceuticals Says US FDA Clears Second Netherton Syndrome Pivotal Study

MT Newswires Live
·
22 May

Quoin Pharmaceuticals’ QRX003 Gains Orphan Drug Status

TIPRANKS
·
21 May

Quoin Pharmaceuticals Announces EMA Orphan Drug Designation for QRX003, Advancing Late-Stage Trials for Netherton Syndrome Treatment

Reuters
·
21 May

Quoin Pharmaceuticals announces EMA grants ODD for QRX003

TIPRANKS
·
20 May

Quoin Pharmaceuticals Reports Q1 2025 Progress and Financials

TIPRANKS
·
16 May

Quoin Pharmaceuticals Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Quoin Pharmaceuticals Q1 EPS $(6.50) Misses $(6.07) Estimate

Benzinga
·
13 May

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Dow Jones
·
13 May

Quoin Pharmaceuticals Ltd expected to post a loss of $6.07 a share - Earnings Preview

Reuters
·
09 May

Quoin Pharmaceuticals Ltd expected to post a loss of $6.07 a share - Earnings Preview

Reuters
·
05 May

Quoin Pharmaceuticals Regains Compliance With Nasdaq

Reuters
·
30 Apr

Quoin Pharmaceuticals regains compliance with Nasdaq minimum bid price rule

TIPRANKS
·
30 Apr

Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire
·
30 Apr

Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series

TIPRANKS
·
10 Apr

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

GlobeNewswire
·
10 Apr

Quoin Pharmaceuticals Ltd – ADR trading halted, news pending

TIPRANKS
·
09 Apr

Quoin Pharmaceuticals Changes ADS Ratio to Meet Nasdaq Rule

MT Newswires Live
·
05 Apr

ADRs Advance; Quoin Pharmaceuticals Ltd. Climbs 38%

Dow Jones
·
03 Apr

Quoin Pharmaceuticals - Subject's Skin Almost Completely Healed After 6 Weeks Of Qrx003

Reuters
·
02 Apr